How much is Nimbus Therapeutics worth in 2026?

Nimbus Therapeutics has a current valuation of N/A based on their Later Stage VC (Series E) round and secondary market data.

How much funding has Nimbus Therapeutics raised?

Nimbus Therapeutics has raised N/A in total funding across 2 funding rounds.

Nimbus Therapeutics

Drug Discovery

Nimbus Therapeutics valuation and funding history | Last updated: August 7, 2023 | 2 funding rounds

Current Valuation

N/A

As of August 7, 2023

Total Funding Raised

N/A

Across 2 rounds

Last Round

Later Stage VC (Series E)

$210.0M

Last Funding

Aug 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 7, 2023	Later Stage VC (Series E)	$210.0M	N/A	-
September 2, 2022	Later Stage VC	$125.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Nimbus Therapeutics is currently valued at N/A as of August 7, 2023.

Track Nimbus Therapeutics Valuation Updates

Get notified when Nimbus Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Nimbus Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Nimbus Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Nimbus Therapeutics Worth in 2026?

Nimbus Therapeutics is a leading private company in the Drug Discovery sector. Track Nimbus Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Nimbus Therapeutics Valuation is Determined

Private company valuations like Nimbus Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.